Board Meeting20 Jul 2026, 10:44 am
Ajanta Pharma Board Meeting on July 30, 2026 for Q1 FY27 Results
AI Summary
Ajanta Pharma Ltd has announced that its Board of Directors will convene on July 30, 2026. The primary agenda item for this meeting is to consider and approve the unaudited consolidated and standalone financial results for the first quarter ended June 30, 2026. This notification is in compliance with Regulation 29 of the Listing Regulations.
Key Highlights
- Board meeting scheduled for July 30, 2026.
- To consider and approve Q1 FY27 financial results.
- Results will be both consolidated and standalone.
- Results for the quarter ended June 30, 2026.
Price Impact
More from AJANTPHARM